Dexcom, Beyond Type 2 and Retta Establish National Glucose Awareness Week to Close the Glucose Knowledge Gap
DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, in ...
EXCLUSIVE: Retta details the moment she was diagnosed with Type 2 diabetes
Retta reveals the first symptoms of her Type 2 diabetes. The actor shares the lifestyle changes she made and the glucose ...
Le Lézard1m
AHEAD Unveils Panel-Agnostic Automated AML Diagnosis Solution
AHEAD Medicine Corporation, a pioneering AI HealthTech company, is excited to announce a significant advancement in its flagship product, Cyto-Copilot. The new analysis module now supports AML versus ...
Le Lézard4m
Unlock Health Launches Health Risk Assessment (HRA) Product Suite to Enhance the Consumer Journey to Care and Drive Growth Across Key Service Lines
Unlock Health, a tech-enabled growth platform for healthcare systems, hospitals, provider groups, and treatment center facilities, today announced the launch of its advanced suite of Health Risk ...